Cronos (CRON) Total Non-Current Liabilities (2016 - 2026)

Cronos' (CRON) quarterly Total Non-Current Liabilities came in at $47.5 million in Q1 2026, up 23.65% year-on-year from $38.5 million in Q1 2025, and down 11.04% quarter-over-quarter from $53.4 million in Q4 2025.

Cronos (CRON) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends

Cronos' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $47.5 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 23.65% year-over-year to $47.5 million in Q1 2026; TTM through Mar 2026 was $47.5 million, a 23.65% increase from a year earlier, with the FY2025 full-year figure at $53.4 million, changed N/A from the prior year.
  • Total Non-Current Liabilities retreated to $47.5 million in Q1 2026 per CRON's latest filing, from $53.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $73.8 million in Q4 2022 and bottomed at $30.7 million in Q2 2023.
  • The 5-year median for Total Non-Current Liabilities is $45.6 million (2022), against an average of $45.2 million.
  • Across the five-year window, Total Non-Current Liabilities slumped 85.45% in 2022 and soared 59.5% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $73.8 million in 2022, then declined by 12.15% to $64.8 million in 2023, then retreated by 20.42% to $51.6 million in 2024, then gained by 3.62% to $53.4 million in 2025, then declined by 11.04% to $47.5 million in 2026.
  • Per Business Quant, the three latest CRON Total Non-Current Liabilities figures stand at $47.5 million (Q1 2026), $53.4 million (Q4 2025), and $45.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn 47.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47.55 Mn
Dec 31, 2025 53.45 Mn
Sep 30, 2025 45.66 Mn
Jun 30, 2025 44.34 Mn
Mar 31, 2025 38.45 Mn
Sep 30, 2024 51.58 Mn
Jun 30, 2024 34.12 Mn
Mar 31, 2024 34.72 Mn
Dec 31, 2023 64.81 Mn
Sep 30, 2023 32.34 Mn
Jun 30, 2023 30.65 Mn
Mar 31, 2023 33.18 Mn
Dec 31, 2022 73.78 Mn
Sep 30, 2022 46.23 Mn
Jun 30, 2022 46.68 Mn
Mar 31, 2022 45.53 Mn
Dec 31, 2021 81.59 Mn
Sep 30, 2021 44.25 Mn
Jun 30, 2021 208.70 Mn
Mar 31, 2021 313.00 Mn